Cathay Biotech Inc.
688065.SS · SHH
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | CN¥142,007 | CN¥0 | CN¥136,950 | CN¥0 |
| Dep. & Amort. | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Deferred Tax | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Stock-Based Comp. | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Change in WC | CN¥0 | -CN¥196,108 | CN¥0 | CN¥0 |
| Other Non-Cash | -CN¥208,227 | CN¥447,932 | -CN¥49,461 | CN¥144,913 |
| Operating Cash Flow | -CN¥66,221 | CN¥251,824 | CN¥87,489 | CN¥144,913 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -CN¥187,865 | -CN¥78,508 | -CN¥279,727 | -CN¥199,364 |
| Net Acquisitions | CN¥25,086 | CN¥0 | CN¥0 | CN¥0 |
| Inv. Purchases | CN¥1,500,000 | -CN¥1,500,000 | -CN¥25,500 | CN¥0 |
| Inv. Sales/Matur. | -CN¥400,079 | CN¥400,079 | CN¥0 | CN¥0 |
| Other Inv. Act. | -CN¥906,411 | CN¥10,024 | CN¥0 | -CN¥9,794 |
| Investing Cash Flow | CN¥30,731 | -CN¥1,168,405 | -CN¥305,227 | -CN¥209,158 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -CN¥275,561 | -CN¥1,078,769 | -CN¥236,596 | CN¥584,582 |
| Stock Issued | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Stock Repurch. | CN¥502 | -CN¥502 | CN¥0 | CN¥0 |
| Dividends Paid | CN¥0 | -CN¥2,253 | -CN¥12,871 | -CN¥11,388 |
| Other Fin. Act. | -CN¥289,054 | CN¥52,500 | CN¥5,914,725 | -CN¥10,023 |
| Financing Cash Flow | -CN¥564,112 | -CN¥1,029,025 | CN¥5,665,258 | CN¥563,171 |
| Forex Effect | -CN¥14,261 | -CN¥6,472 | CN¥2,367 | CN¥52,969 |
| Net Chg. in Cash | -CN¥613,863 | -CN¥1,952,077 | CN¥5,449,887 | CN¥551,895 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | CN¥8,720,311 | CN¥10,635,851 | CN¥5,185,965 | CN¥4,634,069 |
| End Cash | CN¥8,106,448 | CN¥8,683,774 | CN¥10,635,851 | CN¥5,185,965 |
| Free Cash Flow | -CN¥254,085 | CN¥173,316 | -CN¥192,238 | -CN¥54,450 |